论文部分内容阅读
目的 :评价乳腺癌脑转移 3种治疗方法 (放疗、化疗、放化疗 )的疗效及其预后因素分析。方法 :放疗2 0例、化疗 11例、放化疗 32例。结果 :放疗组、化疗组和放化疗组的有效率分别为 30 %、2 7.3%、5 9.4%;中位生存期分别为 6 .2月、5 .7月、8.9月 ;1年生存率分别为 35 %、36 .4%、5 9.4%。放化疗组的疗效明显优于放疗组及化疗组 (P<0 .0 5 ) ;而放疗组疗效与化疗组的疗效之间无显著性差异 (P>0 .0 5 )。结论 :放化疗是治疗乳腺癌脑转移较有效的治疗方案
Objective: To evaluate the efficacy and prognostic factors of three therapeutic methods for breast cancer brain metastases (radiotherapy, chemotherapy, radiochemotherapy). Methods: Twenty cases received radiotherapy, 11 cases received chemotherapy, and 32 cases received radiochemotherapy. Results: The radiotherapy, chemotherapy and radiochemotherapy groups were 30%, 27.3%, and 5.9%, respectively; the median survival time was 6.2 months, 5.7%, and 8.9 months; the 1-year survival rate They were 35%, 36.4%, and 5 9.4%, respectively. The efficacy of radiotherapy and chemotherapy group was significantly better than that of radiotherapy group and chemotherapy group (P<0.05). There was no significant difference between radiotherapy group and chemotherapy group (P>0.05). Conclusion : Radiotherapy and chemotherapy is an effective treatment for breast cancer brain metastasis